Reverse engineering the anti-MUC1 hybridoma antibody 139H2 by mass spectrometry-based de novo sequencing
Preprint
Abstract
Mucin 1 (MUC1) is a transmembrane mucin expressed at the apical surface of epithelial cells at different mucosal surfaces including breast and intestine. In the gastrointestinal tract, MUC1 has a barrier function against bacterial invasion, but can also serve as an entry receptor for pathogenic Salmonella bacteria. Moreover, MUC1 is well known for its aberrant expression and glycosylation in adenocarcinomas The MUC1 extracellular domain contains a variable number of tandem repeats (VNTR) of 20 amino acids, which are heavily O -linked glycosylated.. Monoclonal antibodies against the MUC1 VNTR can be powerful tools because of their multiplicity of binding and possible applications in the diagnosis and treatment of MUC1-expressing cancers. One such antibody is the hybridoma mouse monoclonal 139H2, which is also widely used as a research tool to study non-cancer MUC1. Here we report direct mass spectrometry-based sequencing of hybridoma-derived 139H2 IgG, which enabled reverse engineering of a recombinant 139H2. The performance of the reverse engineered 139H2 IgG and its Fab fragment were validated by comparison to the hybridoma-derived product in Western blot and immunofluorescence microscopy. The reverse engineering of 139H2 allowed us to characterize binding to the VNTR peptide epitope by surface plasmon resonance (SPR) and solve the crystal structure of the 139H2 Fab fragment in complex with the MUC1 VNTR peptide. These analyses reveal the molecular basis for 139H2 binding specificity to MUC1 and its tolerance to O -glycosylation of the VNTR. The available sequence of 139H2 will allow further development of MUC1-related diagnostics, targeting and treatment strategies.Keywords
This publication has 48 references indexed in Scilit:
- MUC1 Limits Helicobacter pylori Infection both by Steric Hindrance and by Acting as a Releasable DecoyPLOS Pathogens, 2009
- MUC1 cell surface mucin is a critical element of the mucosal barrier to infectionJournal of Clinical Investigation, 2007
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- IMGT® databases, web resources and tools for immunoglobulin and T cell receptor sequence analysis, http://imgt.cines.frLeukemia, 2003
- Crystal structure at 1.95 å resolution of the breast tumour-specific antibody SM3 complexed with its peptide epitope reveals novel hypervariable loop recognitionJournal of Molecular Biology, 1998
- Alterations of O-glycan biosynthesis in human colon cancer tissuesGlycobiology, 1994
- Comparison of 131I‐labelled anti‐episialin 139H2 with cisplatin, cyclophosphamide or external‐beam radiation for anti‐tumor efficacy in human ovarian cancer xenograftsInternational Journal of Cancer, 1992
- Human ovarian cancer xenografts in nude mice: Characterization and analysis of antigen expressionInternational Journal of Cancer, 1991
- Monoclonal antibodies against human milk‐fat globule membranes detecting differentiation antigens of the mammary gland and its tumorsInternational Journal of Cancer, 1984